Cite
HARVARD Citation
Harrington, P. et al. (2021). Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia. British journal of haematology. pp. 999-1006. [Online].